USD 44.61
(-7.83%)
Year | Eps | Eps Growth |
---|---|---|
2024 | -3.60 USD | 0.0% |
2023 | -3.60 USD | 10.89% |
2022 | -4.04 USD | -28.25% |
2021 | -3.15 USD | 11.76% |
2020 | -3.57 USD | 8.93% |
2019 | -3.92 USD | -46.27% |
2018 | -2.68 USD | 15.19% |
2017 | -3.16 USD | -34.47% |
2016 | -2.35 USD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q1 | -0.75 USD | 7.41% |
2024 Q2 | -0.79 USD | -5.33% |
2024 Q3 | -1.47 USD | -86.08% |
2023 FY | - USD | 10.89% |
2023 Q4 | -0.81 USD | 19.8% |
2023 Q2 | -1.04 USD | -40.54% |
2023 Q1 | -0.74 USD | 18.68% |
2023 Q3 | -1.01 USD | 2.88% |
2022 Q3 | -1.08 USD | 4.42% |
2022 Q4 | -0.91 USD | 15.74% |
2022 FY | - USD | -28.25% |
2022 Q1 | -0.91 USD | -8.33% |
2022 Q2 | -1.13 USD | -24.18% |
2021 FY | - USD | 11.76% |
2021 Q4 | -0.84 USD | -2.44% |
2021 Q1 | -0.72 USD | -30.91% |
2021 Q2 | -0.78 USD | -8.33% |
2021 Q3 | -0.82 USD | -5.13% |
2020 Q2 | -0.85 USD | 49.7% |
2020 FY | - USD | 8.93% |
2020 Q1 | -1.69 USD | -76.04% |
2020 Q4 | -0.55 USD | 17.91% |
2020 Q3 | -0.67 USD | 21.18% |
2019 Q4 | -0.96 USD | -4.35% |
2019 FY | - USD | -46.27% |
2019 Q3 | -0.92 USD | 1.08% |
2019 Q2 | -0.93 USD | 21.19% |
2019 Q1 | -1.18 USD | -59.46% |
2018 Q1 | -0.90 USD | 1.1% |
2018 Q2 | -0.90 USD | 0.0% |
2018 FY | - USD | 15.19% |
2018 Q3 | -0.94 USD | -4.44% |
2018 Q4 | -0.74 USD | 21.28% |
2017 FY | - USD | -34.47% |
2017 Q3 | -6.02 USD | 0.0% |
2017 Q4 | -0.91 USD | 84.88% |
2016 FY | - USD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Bionano Genomics, Inc. | -6.81 USD | 47.137% |
Prenetics Global Limited | -5.58 USD | 35.484% |
Star Equity Holdings, Inc. | 7.42 USD | 148.518% |
CareDx, Inc | -3.54 USD | -1.695% |
Exact Sciences Corporation | -1.13 USD | -218.584% |
Exagen Inc. | -1.34 USD | -168.657% |
Inotiv, Inc. | -4.10 USD | 12.195% |
Guardant Health, Inc. | -4.28 USD | 15.888% |
Biodesix, Inc. | -0.64 USD | -462.5% |
BioNexus Gene Lab Corp. | -0.17 USD | -2017.647% |
Precipio, Inc. | -4.51 USD | 20.177% |
iSpecimen Inc. | -1.23 USD | -192.683% |
Natera, Inc. | -3.78 USD | 4.762% |
Aspira Women's Health Inc. | -1.81 USD | -98.895% |
Standard BioTools Inc. | -0.94 USD | -282.979% |
23andMe Holding Co. | -1.40 USD | -157.143% |
Castle Biosciences, Inc. | -2.14 USD | -68.224% |
Personalis, Inc. | -2.25 USD | -60.0% |
Aclaris Therapeutics, Inc. | -1.27 USD | -183.465% |
Applied DNA Sciences, Inc. | -15.21 USD | 76.331% |
OpGen, Inc. | -41.47 USD | 91.319% |
T2 Biosystems, Inc. | -19.19 USD | 81.24% |
Myriad Genetics, Inc. | -1.39 USD | -158.993% |
ICON Public Limited Company | 7.46 USD | 148.257% |
NeoGenomics, Inc. | -0.70 USD | -414.286% |
Star Equity Holdings, Inc. | 7.42 USD | 148.518% |
IDEXX Laboratories, Inc. | 10.17 USD | 135.398% |
RadNet, Inc. | 0.05 USD | 7615.658% |
MDxHealth SA | -1.66 USD | -116.867% |
Psychemedics Corporation | -0.72 USD | -400.0% |
Illumina, Inc. | -7.35 USD | 51.02% |
Check-Cap Ltd. | -3.00 USD | -20.0% |
DarioHealth Corp. | -1.93 USD | -86.528% |
Fulgent Genetics, Inc. | -5.63 USD | 36.057% |
Sera Prognostics, Inc. | -1.16 USD | -210.345% |
ENDRA Life Sciences Inc. | -1.11 USD | -224.324% |
OPKO Health, Inc. | -0.25 USD | -1340.0% |
Medpace Holdings, Inc. | 9.20 USD | 139.13% |
Neogen Corporation | -0.04 USD | -8175.862% |
Intelligent Bio Solutions Inc. | -6.38 USD | 43.574% |
Prenetics Global Limited | -5.58 USD | 35.484% |
Mainz Biomed B.V. | -1.62 USD | -122.222% |
bioAffinity Technologies, Inc. | -0.91 USD | -295.604% |
Trinity Biotech plc | -3.14 USD | -14.65% |
Neuronetics, Inc. | -1.05 USD | -242.857% |
Sotera Health Company | 0.18 USD | 2100.0% |
bioAffinity Technologies, Inc. | -0.91 USD | -295.604% |